Background: Studies suggest volatile anesthetics and opioids may enhance the malignant
potential of cancer cells. The objective of this single institution retrospective study was to …

Background Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
(CRS/HIPEC) offer survival benefits in well-selected patients with peritoneal tumors. The …

BACKGROUND: The Acute Pain Service (APS) was initially introduced to optimize
multimodal postoperative pain control. The aim of this study was to evaluate the association …

Methods: Intra-operative data were collected for cases done over 1 year (24 cases) and
analysed for the primary outcome of post-operative ventilation> 24 h, and secondary …

Objectives Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy
(HIPEC) is associated with increased morbidity and mortality. We retrospectively analysed …

Background Hyperthermic intraperitoneal chemotherapy (HIPEC) is commonly used to treat
peritoneal surface malignancies. We aimed to identify risk factors of intraoperative patient …

Background Opioid‐free anesthesia (OFA) provides analgesia minimizing opioids. OFA has
not been evaluated in cytoreductive surgery (CRS) with or without heated intraperitoneal …

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy has emerged as one
of the primary modalities of treatment of diffuse peritoneal malignancies. It is a complex …

METHODS We reviewed CRS and HIPEC procedures performed at our centre from January
1997 to December 2012, focusing on perioperative events and anaesthetic implications …

Background Several studies in adult patients have suggested an unfavorable association
between opioid consumption and cancer progression. Aims This study investigated the …